Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Oncobiologics, Inc. | 118,573 | reported | 21 Dec 2016 | tx 4+155,942−153,311 |
| Akero Therapeutics, Inc. | 0 | reported | 09 Dec 2025 | tx 12+325,899−325,899 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 21,263 | — | |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 5,088 | — | |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 17,784 | — | deriv |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 73,700 | — | deriv |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 204,616 | — | deriv |
| 15 Aug 2025 | EXERCISE | Akero Therapeutics, Inc. | 2,600 | 19.62 USD | |
| 15 Aug 2025 | EXERCISE | Akero Therapeutics, Inc. | 2,600 | 0.00 USD | deriv |
| 30 Jun 2025 | GRANT_AWARD | Akero Therapeutics, Inc. | 299 | 23.87 USD | |
| 18 Jun 2025 | SALE | Akero Therapeutics, Inc. | 848 | 54.84 USD | |
| 16 Dec 2024 | GRANT_AWARD | Akero Therapeutics, Inc. | 24,300 | 0.00 USD | |
| 16 Dec 2024 | GRANT_AWARD | Akero Therapeutics, Inc. | 73,700 | 0.00 USD | deriv |
| 29 Apr 2024 | GRANT_AWARD | Akero Therapeutics, Inc. | 225,000 | 0.00 USD | deriv |
| 21 Dec 2016 | GRANT_AWARD | Oncobiologics, Inc. | 40,000 | 0.00 USD | |
| 09 Nov 2016 | EXERCISE | Oncobiologics, Inc. | 115,942 | — | |
| 09 Nov 2016 | CONVERSION | Oncobiologics, Inc. | 115,942 | 0.00 USD | |
| 11 Nov 2016 | SALE | Oncobiologics, Inc. | 37,369 | 3.75 USD |